Back

Functional and Computational Interrogation of the Juvenile Idiopathic Arthritis Risk Loci Identifies Candidate Causal SNPs and Target Genes in CD4+ T cells

Jiang, K.; Haley, E. K.; Barshad, G.; He, A.; Rogic, A.; Rice, E. J.; Sudman, M.; Thompson, S. D.; Danko, C. G.; Jarvis, J. N.

2025-12-16 genetic and genomic medicine
10.64898/2025.12.15.25342296
Show abstract

GWAS have identified multiple genetic regions that confer risk for juvenile idiopathic arthritis (JIA). However, identifying the single nucleotide polymorphisms (SNPs) that drive disease risk has been impeded by the fact that the SNPs used to identify risk loci are in linkage disequilibrium (LD) with hundreds of other SNPs. Since the causal SNPs remain unknown, it is difficult to identify target genes and thus use genetic information to elucidate disease biology and inform patient care. We next used existing genotyping data from 3,939 children with JIA and 14,412 healthy controls to identify SNPs on JIA risk haplotypes that: present within open chromatin in multiple immune cell types and more common in children with JIA than the controls (p<0.05) in the genotyping data sets. We identified SNPs within cis-regulatory regions (CREs) using precision run-on sequencing data, and identified likely target genes using MicroC in both resting and activated CD4+ T cells. We identified 138 SNPs within the PROseq-identified CREs, and n=41 genes with which these CREs physically interacted. Data from GTEx corroborated these analyses by showing allelic effects for SNPs within the CREs in the ERAP2 and IRF1 risk loci. We further corroborated IRF1 allelic effects using a luciferase reporter assay. Our findings significantly reduce the genomic search space for risk-driving variants and target genes and support the roles of IRF1, ERAP2 and LNPEP in driving risk for JIA.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Nature Communications
based on 483 papers
Top 2%
16.1%
2
The American Journal of Human Genetics
based on 77 papers
Top 2%
6.1%
3
Nature Genetics
based on 72 papers
Top 3%
6.1%
4
Genome Medicine
based on 56 papers
Top 1%
5.6%
5
Cell Genomics
based on 34 papers
Top 0.3%
4.7%
6
Scientific Reports
based on 701 papers
Top 40%
4.7%
7
Human Molecular Genetics
based on 28 papers
Top 0.3%
4.7%
8
Annals of the Rheumatic Diseases
based on 23 papers
Top 0.6%
3.1%
50% of probability mass above
9
Nature
based on 58 papers
Top 2%
2.9%
10
Genome Biology
based on 14 papers
Top 0.1%
2.9%
11
Proceedings of the National Academy of Sciences
based on 100 papers
Top 4%
2.6%
12
JCI Insight
based on 63 papers
Top 2%
2.6%
13
Science Advances
based on 52 papers
Top 0.8%
2.4%
14
Human Genetics and Genomics Advances
based on 39 papers
Top 0.7%
2.4%
15
Arthritis & Rheumatology
based on 21 papers
Top 0.8%
1.8%
16
npj Genomic Medicine
based on 18 papers
Top 1%
1.6%
17
PLOS Genetics
based on 39 papers
Top 4%
1.3%
18
iScience
based on 74 papers
Top 5%
1.3%
19
eLife
based on 262 papers
Top 26%
0.9%
20
PLOS ONE
based on 1737 papers
Top 94%
0.8%
21
Nature Medicine
based on 88 papers
Top 14%
0.8%
22
Frontiers in Immunology
based on 140 papers
Top 7%
0.8%
23
BMC Medical Genomics
based on 12 papers
Top 1%
0.7%
24
Frontiers in Genetics
based on 32 papers
Top 6%
0.7%
25
Communications Biology
based on 36 papers
Top 5%
0.7%
26
Journal of Clinical Investigation
based on 50 papers
Top 4%
0.7%
27
Human Genetics
based on 14 papers
Top 2%
0.7%